Wells Fargo & Company MN Cuts Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)
Wells Fargo & Company MN lessened its position in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE – Free Report) by 1.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 74,304 shares of the company’s stock after selling 1,283 […]
Wells Fargo & Company MN lessened its position in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE – Free Report) by 1.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 74,304 shares of the company’s stock after selling 1,283 […]
